Neuland Laboratories Dette/Equité
Quel est le Dette/Equité de Neuland Laboratories?
Le Dette/Equité de Neuland Laboratories Limited est 0.73
Quelle est la définition de Dette/Equité?
Le ratio d'endettement et d'équité est un ratio financier indiquant la proportion relative des capitaux propres et de la dette utilisée pour financer les actifs d'une entreprise.
The debt to equity ratio is generally calculated by dividing debt by equity. The D/E ratio is also known as risk, gearing or leverage. The two components are often taken from the firm's balance sheet or statement of financial position (so-called book value), but the ratio may also be calculated using market values for both, if the company's debt and equity are publicly traded, or using a combination of book value for debt and market value for equity financially. Preferred stock can be considered part of debt or equity. Attributing preferred shares to one or the other is partially a subjective decision but will also take into account the specific features of the preferred shares. When used to calculate a company's financial leverage, the debt usually includes only the long-term debt.
Dette/Equité des entreprises dans Health Care secteur sur BSE par rapport à Neuland Laboratories
Que fait Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Entreprises avec dette/equité similaire à Neuland Laboratories
- Kinross Gold a Dette/Equité de 0.73
- Akme Star Housing Finance a Dette/Equité de 0.73
- Premier Inc a Dette/Equité de 0.73
- Helen of Troy Ltd a Dette/Equité de 0.73
- Skillcast plc a Dette/Equité de 0.73
- Irish Residential Properties REIT Plc a Dette/Equité de 0.73
- Neuland Laboratories a Dette/Equité de 0.73
- RevoluGROUP Canada a Dette/Equité de 0.73
- Nanjing Wondux Environmental Protection Technology a Dette/Equité de 0.73
- Century Communities Inc a Dette/Equité de 0.73
- Culp a Dette/Equité de 0.73
- Steel City Securities a Dette/Equité de 0.73
- Acadia Pharmaceuticals Inc a Dette/Equité de 0.73